Regener8 Member Shortlisted for Business for Life Awards
25 Oct 2011
Regener8 member Reinnervate has been shortlisted for two categories at the Cels Business for Life Awards 2011.
The Awards celebrate the achievements of the Healthcare and Life Sciences Sector in the North of England in areas such as Innovation and Outstanding Growth. These awards not only recognise and reward the North of England’s top companies in the industry but also promote new technologies and companies to the regions healthcare sector.
Reinnervate was set up by scientists at Durham University. They have developed novel artificial skin constructs for routine use in research, screening and compound testing programmes. Funding and support from Regener8, via the N8 Research Partnership (a collaboration of the North’s 8 research-intensive universities) helped Reinnervate to develop their products, which are being sold worldwide, supporting the growth of skin cells derived from human stem cells and so allowing a consistent supply of material for investigative research in this important therapeutic area.
Reinnervate are shortlisted for the Technology Award, which is awarded for the development of a new or existing technology resulting in actual or potential substantial improvements in the Healthcare and Life Sciences sector, either financial, environmental or service.
Prof. Stefan Przyborski of Reinnervate is also nominated for the HealthConnect Award, which recognises individuals who have made a significant contribution the healthcare and life science sector.
The winners will be revealed at an awards ceremony at St James Park in Newcastle upon Tyne on Wednesday 9 November.
Open to all, ticket prices for the awards ceremony are £39 for members and £47 for non members; to attend please visit http://businessforlife2011.eventbrite.com to book.
